Description
Loracarbef is a new orally active, broad-spectrum cephalosporin suitable for twice a
day dosing. It is approved for use in both adults and children for the treatment of upper
and lower respiratory tract infections, urinary tract and skin infections.
Chemical Properties
Melting point 205～215℃ (decomposition). [α]
D21+34.0°(C=0.35, water).
Originator
Kyowa Hakko (Japan)
Uses
LORACARBEF's antibacterial activity is similar to that of cefaclor and cefuroxime aspirin, and it is used for pneumonia, pharyngitis, chronic bronchitis, secondary bacterial infections of mild to moderate acute bronchitis, tonsillitis, etc. caused by susceptible bacteria.
Definition
ChEBI: The monohydrated form of loracarbef.
